Benitec Biopharma Ltd ADR (BNTC) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.00x

Benitec Biopharma Ltd ADR (BNTC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2018, reinvesting $26.00K (capex $26.00K ) from operating cash flow of $5.87 Million. Explore BNTC capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$26.00K
Capex + Investments

Operating Cash Flow

$5.87 Million
USD

Capital Expenditures

$26.00K
USD

Benitec Biopharma Ltd ADR Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Benitec Biopharma Ltd ADR across 1 annual periods. Also explore how large is Benitec Biopharma Ltd ADR's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Benitec Biopharma Ltd ADR (2019–2019)

Year-by-year capital reinvestment analysis for Benitec Biopharma Ltd ADR. For live market cap and broader valuation context, see BNTC market cap overview.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 0.20x $973.40K $4.79 Million $403.40K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow